5-HT6 receptor antagonist
This page covers all 5-HT6 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-HT6 receptor.
Targets
Phase 3 pipeline (1)
- SR121463B · Sanofi · Neurology
SR121463B is a small molecule that acts as a selective and potent inhibitor of the serotonin 5-HT6 receptor.
Patent intelligence
- 5 ht6 receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates